FindTrial
Sign In

Intervention 1: In the intervention group: Methylphenidate tablets orally used with a starting dose of 0.3 mg/kg, twice a day up to a final dose of 1 mg/kg within two weeks and continue treatment unti

2 trials

Sponsors

Vice Chancellor for Research and Technology at Zahedan University of Medical Sciences and Health Ser

Conditions

Attention deficit hyperactivity disorder (ADHD). Disturbance of activity and attention

Phase 2

Investigating the effectiveness of methylphenidate and combination of magnesium and zinc and calcium in treatment of patients with attention deficit hyperactivity disorder (ADHD) in Zahedan City
Active, not recruitingIRCT2015092624209N1
Vice Chancellor for Research and Technology at Zahedan University of Medical Sciences and Health SerAttention deficit hyperactivity disorder (ADHD). Disturbance of activity and attention
Start: 2014-12-22Target: 40Updated: 2018-02-22

Phase 3

Investigating the effectiveness of methylphenidate and multi chain polyunsaturated fatty acids in treatment of patients with attention deficit hyperactivity disorder (ADHD) in Zahedan City
Active, not recruitingIRCT2015092724209N2
Vice Chancellor for Research and Technology at Zahedan University of Medical Sciences and Health SerAttention deficit hyperactivity disorder (ADHD). Disturbance of activity and attention
Start: 2014-12-22Target: 40Updated: 2018-02-22

Related Papers

Effectiveness of methylphenidate and PUFA for the treatment of patients with ADHD: A double-blinded randomized clinical trial.
2017-05-256 citations